Insight, Top 50 Pharma

Biogen Idec: Company Profile

Posted on 02 February 2012

Return to top 50 pharma list

Summary

Website: Biogen

Headquarters: Massachusetts, USA

Ticker Symbol: BIIB (Nasdaq Stock Exchange) IDP (Frankfurt Stock Exchange)

SEC Link: Biogen

Subsidiaries:

Biogen

Biogen Idec International

Biogen Idec New Ventures

Conforma Therapeutics

Fumapharm

IDEC Pharmaceuticals

Syntonix Pharmaceuticals

Top 50 Pharma ranking*: 36

*Ranking based on reported global pharma sales for year ending December 2010.

Sales revenue (USD billions) [% change from 2009]: $3.5 [10.1%]

R&D spend (USD millions): $1249

Top-selling drugs (USD billions): Avonex [3.5]

Partnering activity

View partnering activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

M&A activity

View M&A activity: 2011,2010,2009,2008,2007,2006,2005

Full details on each deal can be found at CurrentAgreements (subscription required)

Available reports from Current Partnering:

Partnering Agreements with Biogen Idec

Partnering Agreements with Big Pharma, 3rd edition

Search all reports

Available resources providing deal coverage for Biogen Idec:

Current Agreements (subscription required)

Request a complimentary trial

Search Current Partnering for mention of Biogen Idec:

Search now

return to top 50 pharma list

Leave a Reply

*

bannerpng
biomarker-world-congress-2012jpg
molecular-diagnostics-june-2012jpg

Latest Tweets